André, T., Pietrantonio, F., Yalcin, S., Ahn, J. B., Dasgupta, S., Chalabi, M., Kim, T., Shiu, K., Corrales, L., Lonardi, S., Kwiatkowski, M., Jiménez-Fonseca, P., Şendur, M. A. N., Jonuskiene, G., Valera, J. S., Gümüş, M., Odeleye-Ajakaye, A., Fogelman, D. R., Adelberg, D. E., Kim, T. W. (2026). KEYSTEP-008: Pembrolizumab (pembro)-based combinations for microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.137